Showing 1 - 10 results of 10 for search 'Rodney J Y Ho', query time: 0.04s Refine Results
  1. 1
    Design and Characterization of a Novel Venetoclax-Zanubrutinib Nano-Combination for Enhancing Leukemic Cell Uptake and Long-Acting Plasma Exposure

    Design and Characterization of a Novel Venetoclax-Zanubrutinib Nano-Combination for Enhancing Leukemic Cell Uptake and Long-Acting Plasma Exposure by James Griffin, Yan Wu, Qingxin Mu, Xinyan Li, Rodney J. Y. Ho

    Published 2023-03-01
    Get full text
    Article
  2. 2
    Inoculation of Pan02 cells produces tumor nodules in mouse pancreas: Characterization of a novel orthotopic pancreatic ductal adenocarcinoma tumor model for interventional studies.

    Inoculation of Pan02 cells produces tumor nodules in mouse pancreas: Characterization of a novel orthotopic pancreatic ductal adenocarcinoma tumor model for interventional studies. by James I Griffin, Xinyue Chen, Luqi Duan, Qingxin Mu, Rodney J Y Ho

    Published 2024-01-01
    Get full text
    Article
  3. 3
    Viral dissemination and immune activation modulate antiretroviral drug levels in lymph nodes of SIV-infected rhesus macaques

    Viral dissemination and immune activation modulate antiretroviral drug levels in lymph nodes of SIV-infected rhesus macaques by Sharat Srinivasula, Paula Degrange, Simone Perazzolo, Andrew Bonvillain, Amanda Tobery, Jacob Kaplan, Hyukjin Jang, Refika Turnier, Michael Davies, Mackenzie Cottrell, Rodney J. Y. Ho, Rodney J. Y. Ho, Michele Di Mascio

    Published 2023-09-01
    Get full text
    Article
  4. 4
    ICAM-1 Targeted Drug Combination Nanoparticles Enhanced Gemcitabine-Paclitaxel Exposure and Breast Cancer Suppression in Mouse Models

    ICAM-1 Targeted Drug Combination Nanoparticles Enhanced Gemcitabine-Paclitaxel Exposure and Breast Cancer Suppression in Mouse Models by Linxi Zhu, Qingxin Mu, Jesse Yu, James I. Griffin, Xiaolin Xu, Rodney J. Y. Ho

    Published 2021-12-01
    Get full text
    Article
  5. 5
    Novel cytochrome P450-2D6 promoter sequence variations in hepatitis C positive and negative subjects(◆)(◆)This work was supported in part by National Institutes of Health grants GM 62883, GM 32165, AI52663, AI 077390, HL 56548. RJYH was also supported by Milo Gibaldi Endowment. KVK was supported in part by NIH grant DK-02957.

    Novel cytochrome P450-2D6 promoter sequence variations in hepatitis C positive and negative subjects(◆)(◆)This work was supported in part by National Institutes of Health grants GM... by Martin T. Ho, Edward J. Kelly, Miklos Bodor, Tot Bui, Kris V. Kowdley, Rodney J.Y. Ho, Ph.D.

    Published 2011-07-01
    Get full text
    Article
  6. 6
    Novel drug combination nanoparticles exhibit enhanced plasma exposure and dose-responsive effects on eliminating breast cancer lung metastasis.

    Novel drug combination nanoparticles exhibit enhanced plasma exposure and dose-responsive effects on eliminating breast cancer lung metastasis. by Qingxin Mu, Jesse Yu, James I Griffin, Yan Wu, Linxi Zhu, Lisa A McConnachie, Rodney J Y Ho

    Published 2020-01-01
    Get full text
    Article
  7. 7
    The systematic development of attributes and levels for a discrete choice experiment of HIV patient preferences for long-acting antiretroviral therapies in the United States

    The systematic development of attributes and levels for a discrete choice experiment of HIV patient preferences for long-acting antiretroviral therapies in the United States by Aaron T. Brah, Douglas Barthold, Brett Hauber, Ann C. Collier, Rodney J. Y. Ho, Vincent C. Marconi, Jane M. Simoni, Susan M. Graham

    Published 2022-02-01
    Get full text
    Article
  8. 8
    Screening for the extracorporeal coagulation activity quality markers (Q-markers) of dried and stir fried ginger

    Screening for the extracorporeal coagulation activity quality markers (Q-markers) of dried and stir fried ginger by Yu Jiang, Chao Bu, Lanlan Fan, Gang Cao, Li Sun, Rodney J.Y. Ho, Deling Wu, Shuangying Gui, Yanquan Han, Yan Hong

    Published 2022-10-01
    Get full text
    Article
  9. 9
    U.S. patient preferences for long‐acting HIV treatment: a discrete choice experiment

    U.S. patient preferences for long‐acting HIV treatment: a discrete choice experiment by Susan M. Graham, Douglas Barthold, Brett Hauber, Aaron T. Brah, Enrique Saldarriaga, Ann C. Collier, Rodney J. Y. Ho, the Emory PREFER Team, Vincent C. Marconi, Jane M. Simoni

    Published 2023-07-01
    Get full text
    Article
  10. 10
    “Lighten This Burden of Ours”: Acceptability and Preferences Regarding Injectable Antiretroviral Treatment Among Adults and Youth Living With HIV in Coastal Kenya

    “Lighten This Burden of Ours”: Acceptability and Preferences Regarding Injectable Antiretroviral Treatment Among Adults and Youth Living With HIV in Coastal Kenya by Jane M. Simoni PhD, Kristin Beima-Sofie MPH, PhD, George Wanje MPH, Zahra H. Mohamed BS, Kenneth Tapia MS, R. Scott McClelland MD, Rodney J. Y. Ho PhD, Ann C. Collier MD, Susan M. Graham MD, MPH, PhD

    Published 2021-03-01
    Get full text
    Article

Search Tools: